BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6298832)

  • 1. Limitations to effect of alpha-MSH on permeability of blood-brain barrier to IV 99mTc-pertechnetate.
    Kastin AJ; Fabre LA
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1199-201. PubMed ID: 6298832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective effects of alpha-MSH and MIF-1 on the blood-brain barrier.
    Sankar R; Domer FR; Kastin AJ
    Peptides; 1981; 2(3):345-7. PubMed ID: 6117842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histamine- and acetylcholine-induced changes in the permeability of the blood-brain barrier of normotensive and spontaneously hypertensive rats.
    Domer FR; Boertje SB; Bing EG; Reddix I
    Neuropharmacology; 1983 May; 22(5):615-9. PubMed ID: 6308494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impromidine-induced changes in the permeability of the blood-brain barrier of normotensive and spontaneously hypertensive rats.
    Boertje SB; Le Beau D; Ward S
    Res Commun Chem Pathol Pharmacol; 1990 Aug; 69(2):249-52. PubMed ID: 1975703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 68Ga-EDTA, [1-11 C]alpha-aminoisobutyric acid, and [99mTc]sodium pertechnetate in an experimental blood-brain barrier lesion.
    Washburn LC; Blair LD; Byrd BL; Sun TT
    Int J Nucl Med Biol; 1985; 12(4):267-9. PubMed ID: 3002998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etoposide induced blood-brain barrier disruption in rats: duration of opening and histological sequelae.
    Spigelman MK; Zappulla RA; Strauchen JA; Feuer EJ; Johnson J; Goldsmith SJ; Malis LI; Holland JF
    Cancer Res; 1986 Mar; 46(3):1453-7. PubMed ID: 3510725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H2-receptors mediate histamine-induced variations in the permeability of the blood-brain barrier of rats.
    Boertje SB; Ward S; Robinson A
    Res Commun Chem Pathol Pharmacol; 1992 May; 76(2):143-54. PubMed ID: 1318565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Permeability of the blood-brain barrier in the rat after local proton irradiation.
    Lundqvist H; Rosander K; Lomanov M; Lukjashin V; Shimchuk G; Zolotov V; Minakova E
    Acta Radiol Oncol; 1982; 21(4):267-71. PubMed ID: 6293269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intracarotid etoposide on opening the blood-brain barrier.
    Spigelman MK; Zappulla RA; Goldberg JD; Goldsmith SJ; Marotta D; Malis LI; Holland JF
    Cancer Drug Deliv; 1984; 1(3):207-11. PubMed ID: 6399858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permeability of the blood-brain barrier is not changed by vasoactive doses of arachidonic acid or prostaglandins in rats.
    Domer FR; Boertje SB; Sampson JB
    Res Commun Chem Pathol Pharmacol; 1985 Apr; 48(1):27-37. PubMed ID: 3922022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low permeability of the blood-brain barrier to nanomolar concentrations of immunoreactive alpha-melanotropin.
    Wilson JF
    Psychopharmacology (Berl); 1988; 96(2):262-6. PubMed ID: 2852821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-brain barrier to pertechnetate following drug-induced hypotension.
    Cook PR; Myers D; Barker M; Jones JG
    Br J Anaesth; 1989 Apr; 62(4):402-8. PubMed ID: 2539849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect and possible mode of action of alpha-melanocyte-stimulating hormone on gonadotropin release in the ovariectomized rat: an in vivo and in vitro analysis.
    Khorram O; DePalatis LR; McCann SM
    Endocrinology; 1984 Jan; 114(1):227-33. PubMed ID: 6418525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity analysis for the effects of gamma-MSH/ACTH-like peptides on cerebral hemodynamics in rats.
    Van Bergen P; Van Der Vaart JG; Kasbergen CM; Versteeg DH; De Wildt DJ
    Eur J Pharmacol; 1996 Dec; 318(2-3):357-68. PubMed ID: 9016926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-melanocyte stimulating hormone increases plasma levels of glucagon and insulin in rabbits.
    Knudtzon J
    Life Sci; 1984 Feb; 34(6):547-54. PubMed ID: 6141515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-MSH and MIF-I effects on catecholamine levels and synthesis in various rat brain areas.
    Kostrzewa RM; Kastin AJ; Spirtes MA
    Pharmacol Biochem Behav; 1975; 3(6):1017-23. PubMed ID: 4815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extraction of [99mTc]-d,l-HM-PAO across the blood-brain barrier.
    Andersen AR; Friberg H; Knudsen KB; Barry DI; Paulson OB; Schmidt JF; Lassen NA; Neirinckx RD
    J Cereb Blood Flow Metab; 1988 Dec; 8(6):S44-51. PubMed ID: 3192642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraventricular administration of MSH induces hyperalgesia in rats.
    Sandman CA; Kastin AJ
    Peptides; 1981; 2(2):231-3. PubMed ID: 7291044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of gamma 2-melanocyte-stimulating hormone and nimodipine on cortical blood flow and infarction volume in two rat models of middle cerebral artery occlusion.
    Herz RC; De Wildt DJ; Versteeg DH
    Eur J Pharmacol; 1996 Jun; 306(1-3):113-21. PubMed ID: 8813623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of morphine-induced analgesia, tolerance and dependence by alpha-melanocyte-stimulating hormone.
    Contreras PC; Takemori AE
    J Pharmacol Exp Ther; 1984 Apr; 229(1):21-6. PubMed ID: 6323687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.